Renaissance Capital logo

Calliditas Therapeutics Priced, Nasdaq: CALT

Swedish biotech developing novel therapies for inflammatory kidney disease.

Industry: Health Care

Latest Trade: $18.36 +0.61 (+3.4%)

First Day Return: +0.5%

Return from IPO: -9.0%

Industry: Health Care

We are a clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. Our lead product candidate, Nefecon, is a proprietary, novel oral formulation of budesonide, an established, highly potent local immunosuppressant, for the treatment of the autoimmune renal disease IgA nephropathy, or IgAN, for which there is a high unmet medical need and there are no approved treatments. IgAN is a progressive, chronic disease that over time results in deterioration of kidney function in patients, many of whom end up at risk of developing end-stage renal disease, or ESRD, with the need for dialysis or kidney transplant. Nefecon is currently the only pharmaceutical candidate in development for IgAN that is intended to be disease-modifying. Nefecon targets the ileum, the distal region of the small intestine, which is the presumed origin of IgAN due to the ileum being the location of the highest concentration of the Peyer’s patches, which are responsible for the production of secretory immunoglobulin A, or IgA, antibodies. Nefecon has been granted orphan drug designation for the treatment of IgAN in the United States and the European Union.
more less
IPO News for Calliditas Therapeutics
more
IPO Data
IPO File Date 05/14/2020
Offer Price $19.50
Price Range $19.50 - $19.50
Offer Shares (mm) 4.6
Deal Size ($mm) $90
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 06/04/2020
Offer Price $19.50
Price Range $19.50 - $19.50
Offer Shares (mm) 4.6
Deal Size ($mm) $90
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Stockholm, Sweden
Founded 2004
Employees 24
Website www.calliditas.se/en/